Leal Therapeutics

Worcester, United States

Leal Therapeutics develops novel therapeutics for patients.

$30.0M raised

Aug 2025

Series A

Medical Therapeutics

Top Investors

OrbiMedDementia Discovery FundNewpath ManagementAlexandria Venture InvestmentsEuclidean Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Leal Therapeutics

How much funding has Leal Therapeutics raised?

Leal Therapeutics has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.

Who are Leal Therapeutics's investors?

Leal Therapeutics's investors include OrbiMed, Dementia Discovery Fund, Newpath Management, Alexandria Venture Investments, Euclidean Capital.

Where is Leal Therapeutics headquartered?

Leal Therapeutics is headquartered in Worcester, United States.

What does Leal Therapeutics do?

Leal Therapeutics develops novel therapeutics for patients.

What stage is Leal Therapeutics at?

Leal Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 27, 2025.

MLA

"Leal Therapeutics — Funding & Investors." VCBacked, August 27, 2025, https://www.vcbacked.co/company/leal-therapeutics. Accessed June 10, 2026.

APA

VCBacked. (2025). Leal Therapeutics — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/leal-therapeutics

Wikipedia (cite web)

{{cite web |title=Leal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/leal-therapeutics |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 27, 2025.

Similar Companies in Medical

Autoimmunity BioSolutions

Houston$2.0M